New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
The Cooper Companies, Inc.
COO
Shape
US Flag

NASDAQ

21B

Medical - Instruments & Supplies

Next Earning date - 05 Dec 2024

21B

Medical - Instruments & Supplies

Next Earning date - 05 Dec 2024

107.82USD
Shape0.52 ( 0.48%)
favorite-chart

Relative Strenght

22
favorite-chart

Volume Buzz

77%
favorite-chart

Earning Acce

Yes
favorite-chart

Dist 52w H.

4%

Quote Panel

Shape
Updated October 28, 2024
1W 1.88 % 1M -2.28 % 3M 16.42 % 1Y 39.32 %

Key Metrics

Shape
  • Market Cap

    21.47B


  • Shares Outstanding

    199.16M


  • Share in Float

    198.15M


  • Dividende

    0.02


  • Earning Date

    05 Dec 2024


  • Price Target

    107.82


  • Average Volume

    1.09M


  • Beta

    0.982


  • Range

    75.935-112.38


  • Industry

    Medical - Instruments & Supplies


  • Website

    https://www.coopercos.com


  • Sector

    Healthcare


Fundamentals

Shape

30.54x

P/E Ratio

5.64x

P/S Ratio

2.71x

P/B Ratio

0.3

Debt/Equity

9.4%

Net Margin

$1.8

EPS

How COO compares to sector?

P/E Ratio

Relative Strength

Shape

COO

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$4B

Shape319%

2025-Revenue

$3.24

Shape511%

2025-EPS

$901M

Shape220%

2025-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

Jefferies

upgrade

Previous: Not converted

2024-07-16

Now: Buy

Deutsche Bank

initialise

Previous: Not converted

2023-10-05

Now: Buy

Cantor Fitzgerald

upgrade

Previous: Not converted

2022-11-30

Now: Overweight

Piper Sandler

downgrade

Previous: Overweight

2022-11-30

Now: Neutral

Earnings GrowthShape

status-upYoY

Current

Estimates

Q4.22

arrow
arrow

-16%

0.69
vs 0.82

Q1.23

arrow
arrow

-10%

0.73
vs 0.81

Q2.23

arrow
arrow

-5%

0.77
vs 0.81

Q3.23

arrow
arrow

+5%

0.84
vs 0.8

Q4.23

arrow
arrow

+26%

0.87
vs 0.69

Q1.24

arrow
arrow

+16%

0.85
vs 0.73

Q2.24

arrow
arrow

+10%

0.85
vs 0.77

Q3.24

arrow
arrow

+14%

0.96
vs 0.84

Q4.24

arrow
arrow

+15%

1
vs 0.87

Q1.25

arrow
arrow

+12%

0.95
vs 0.85

Sales GrowthShape

status-upYoY

Current

Estimates

Q4.22

arrow
arrow

+12%

848.1M  vs 759.1M

Q1.23

arrow
arrow

+9%

858.5M  vs 787.2M

Q2.23

arrow
arrow

+6%

877.4M  vs 829.8M

Q3.23

arrow
arrow

+10%

930.2M  vs 843.4M

Q4.23

arrow
arrow

+9%

927.1M  vs 848.1M

Q1.24

arrow
arrow

+9%

931.6M  vs 858.5M

Q2.24

arrow
arrow

+7%

942.6M  vs 877.4M

Q3.24

arrow
arrow

+8%

1B  vs 930.2M

Q4.24

arrow
arrow

+11%

1B  vs 927.1M

Q1.25

arrow
arrow

+8%

1B  vs 931.6M

Return on EquityShape

status-upQoQ

Q4.22

arrow
arrow

+1%

0.01
vs 0.01

Q1.23

arrow
arrow

+1%

0.01
vs 0.01

Q2.23

arrow
arrow

+1%

0.01
vs 0.01

Q3.23

arrow
arrow

+1%

0.01
vs 0.01

Q4.23

arrow
arrow

+1%

0.01
vs 0.01

Q1.24

arrow
arrow

+1%

0.01
vs 0.01

Q2.24

arrow
arrow

+1%

0.01
vs 0.01

Q3.24

arrow
arrow

+1%

0.01
vs 0.01

Institutionnal OwnershipShape

status-upQoQ

Q3.22

arrow
arrow

540

540
vs 571

-5%

Q4.22

arrow
arrow

567

567
vs 540

5%

Q1.23

arrow
arrow

578

578
vs 567

2%

Q2.23

arrow
arrow

583

583
vs 578

1%

Q3.23

arrow
arrow

588

588
vs 583

1%

Q4.23

arrow
arrow

598

598
vs 588

2%

Q1.24

arrow
arrow

605

605
vs 598

1%

Q2.24

arrow
arrow

623

623
vs 605

3%

Earnings Growth

Latest News